BTIG Research began coverage on shares of Arcturus Therapeutics (NASDAQ:ARCT – Get Free Report) in a research report issued on Tuesday, MarketBeat reports. The brokerage set a “buy” rating and a ...
Sanofi S.A. Part Cert-1.97% €8.03M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback